Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer

Clinical trial NCT03691311 · UNKNOWN

Trial details

NCT number: NCT03691311
Sponsor: Institut Català d'Oncologia
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Neoplasm Female Stage I Breast Cancer Stage II Breast Cancer Hormone Receptor Negative Neoplasm Hormone Receptor Positive Tumor

Start date: 2018-07-05
Primary completion: 2022-07-05
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.